SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001140361-23-012511
Filing Date
2023-03-20
Accepted
2023-03-20 13:58:45
Documents
1
Effectiveness Date
2023-03-20

Document Format Files

Seq Description Document Type Size
1 15-12G ny20008100x3_15-12g.htm 15-12G 10953
  Complete submission text file 0001140361-23-012511.txt   11995
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: 15-12G | Act: 34 | File No.: 001-37929 | Film No.: 23745848
SIC: 2834 Pharmaceutical Preparations